1999
DOI: 10.1097/00001756-199904260-00018
|View full text |Cite
|
Sign up to set email alerts
|

DNA methylation at the putative promoter region of the human dopamine D2 receptor gene

Abstract: DNA methylation was investigated in the putative promoter region of the human dopamine D2 receptor gene (DRD2). Twenty-two DNA samples from two types of cells differentially expressing D2 receptors, striatum and lymphocytes, were subjected to bisulphite modification-based mapping of methylated cytosines. In the tested region, the DNA from lymphocytes exhibited a significantly higher degree of methylation than that from striata. In addition, a significantly higher proportion of methylated to unmethylated cytosi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(23 citation statements)
references
References 6 publications
0
23
0
Order By: Relevance
“…49 Potential causes of pathological DNA hypermethylation which have been indicated as risk factors for schizophrenia include some environmental insults, such as ephemeral ischemia with a consequent increase of DNA methylation, nitric oxide, which has neurodegenerative effects in focal ischemia, intrauterine environmental conditions and maternal malnutrition, alcohol abuse during pregnancy, birth and obstetric complications, as well as exposure to drugs and chemicals, hormonal status (for example, estradiol, estrogen, steroid hormones) and viral infections. 49,165,168 Besides the above data, 49,158,161,162 reported downregulation of histone deacetylase 3 in the temporal cortex of patients with schizophrenia 102 and epigenetic variations in the genes for serotonin 2A (HTR2A) and the dopamine D3 (DRD3) and D2 (DRD2) receptors 163,169 provide further supplementary evidence for the contribution of epigenetic misregulation in schizophrenia. Interestingly, the finding of different degrees of methylation of the promoter area of DRD2 between the right and left striatum 169 introduces the possibility that the epigenetic mechanisms play a role in brain hemisphere laterality 165 and provides a new interpretation of the reported anomalous cerebral asymmetry in affected individuals.…”
Section: Epigenetics: the Meeting Point Of Genes And Environmentmentioning
confidence: 83%
See 1 more Smart Citation
“…49 Potential causes of pathological DNA hypermethylation which have been indicated as risk factors for schizophrenia include some environmental insults, such as ephemeral ischemia with a consequent increase of DNA methylation, nitric oxide, which has neurodegenerative effects in focal ischemia, intrauterine environmental conditions and maternal malnutrition, alcohol abuse during pregnancy, birth and obstetric complications, as well as exposure to drugs and chemicals, hormonal status (for example, estradiol, estrogen, steroid hormones) and viral infections. 49,165,168 Besides the above data, 49,158,161,162 reported downregulation of histone deacetylase 3 in the temporal cortex of patients with schizophrenia 102 and epigenetic variations in the genes for serotonin 2A (HTR2A) and the dopamine D3 (DRD3) and D2 (DRD2) receptors 163,169 provide further supplementary evidence for the contribution of epigenetic misregulation in schizophrenia. Interestingly, the finding of different degrees of methylation of the promoter area of DRD2 between the right and left striatum 169 introduces the possibility that the epigenetic mechanisms play a role in brain hemisphere laterality 165 and provides a new interpretation of the reported anomalous cerebral asymmetry in affected individuals.…”
Section: Epigenetics: the Meeting Point Of Genes And Environmentmentioning
confidence: 83%
“…49,165,168 Besides the above data, 49,158,161,162 reported downregulation of histone deacetylase 3 in the temporal cortex of patients with schizophrenia 102 and epigenetic variations in the genes for serotonin 2A (HTR2A) and the dopamine D3 (DRD3) and D2 (DRD2) receptors 163,169 provide further supplementary evidence for the contribution of epigenetic misregulation in schizophrenia. Interestingly, the finding of different degrees of methylation of the promoter area of DRD2 between the right and left striatum 169 introduces the possibility that the epigenetic mechanisms play a role in brain hemisphere laterality 165 and provides a new interpretation of the reported anomalous cerebral asymmetry in affected individuals. The epigenetic hypothesis provides a new perspective on the etiopathogenesis of schizophrenia and on the various non-Mendelian characteristics of the disease, such as the presence of clinically indistinguishable sporadic and familial cases, phenotypic variance, discordance of monozygotic twins, coincidence of peaks of disease onset with major endocrine rearrangements and the fluctuating course of disease severity.…”
Section: Epigenetics: the Meeting Point Of Genes And Environmentmentioning
confidence: 83%
“…Rapid DNA Bisulphite Modification kit (Human Genetic Signatures Pty Ltd, North Ryde, Australia) according to the manufacturer's instructions. The promoter region of the DRD2 gene, which extends from K239 to C146 (the first nucleotide of exon 1 assigned as position C1), is a CG rich containing region (C15 to C44) that has been reported to be differentially methylated between striatum and lymphocytes (17). We set two forward primers from K239 to K219 (5 0 -TATTTTGGGTGTGG-GTGGGAG-3 0 ) and from K124 to K104 (5 0…”
Section: Methylation Analysis Of the Promoter Region Of The Drd2 Genementioning
confidence: 99%
“…[4][5][6][7][8] To better understand the implications of DNA methylation in disease susceptibility, it is necessary to examine both the qualitative and quantitative status of DNA methylation within the genome.…”
Section: Introductionmentioning
confidence: 99%